Cryo Cell International Inc (CCEL) Institutional Ownership

Ownership Summary

Cryo Cell International Inc (NYSE:CCEL) is held by 17 institutional investors per 13F filings through December 2025.

• These investors collectively held 12.2% of Cryo Cell International's outstanding shares in December 2025, down from 12.2% in September 2025.
• They increased total shares held in Cryo Cell International by 0.49% from the prior quarter, while the number of investors in CCEL decreased 19.05% year over year.
• Of these 17 holders, 6 added to their stakes in Cryo Cell International, 3 trimmed positions, and 8 made no changes.
• In total, institutional investors held 982.9K shares in Cryo Cell International as of December 2025, up by 4.75K shares quarter on quarter, and down 51.0K shares year over year.
• As of December 31, 2025, the biggest holder of Cryo Cell International is HAMILTON LANE ADVISORS LLC at 409.73K shares, representing 5.07% of shares outstanding.
• The most significant purchases of CCEL for the quarter ending December 2025 came from CITADEL ADVISORS LLC (3.13K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.19K), BlackRock, Inc. (516), Royal Bank Of Canada (105), UBS Group AG (82).
• The largest sales of CCEL for the quarter ending December 2025 came from GEODE CAPITAL MANAGEMENT, LLC (247), Tower Research Capital LLC (TRC) (20), Bank Of America Corp /De/ (3).
• Per Business Quant, the top 10 investors in CCEL for the quarter ending December 2025 include HAMILTON LANE ADVISORS LLC (409.73K), SFI Advisors, LLC (165.3K), VANGUARD GROUP INC (150.99K), MassMutual Private Wealth & Trust, FSB (111.04K), GEODE CAPITAL MANAGEMENT, LLC (53.17K), Northern Trust Corp (28.72K), Cerity Partners LLC (19.56K), CITADEL ADVISORS LLC (14.52K), BlackRock, Inc. (12.86K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (12.25K).